S&P Ups Drug Stocks

Also: an analyst's opinion on JDS Uniphase and Qualcomm

S&P upgrades Lilly (LLY ) and Schering Plough (SGP ) to 2 STARS (avoid) from 1 STAR (sell), and upgrades Bristol-Myers (BMY ), Merck (MRK ) and Wyeth (WYE ) to 3 STARS (hold) from 2 STARS (avoid)

To continue reading this article you must be a Bloomberg Professional Service Subscriber.